Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 6/20 | 0.51 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | NPC1 | O15118 | 4/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 4/20 | 0.47 |
| ▸ | TLR7 | Q9NYK1 | 3/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | TLR8 | Q9NR97 | 2/20 | 0.44 |
| ▸ | PPIA | P62937 | 1/20 | 0.43 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6503189 | 0.92 | RAB9A (0.50) | GAAMAPTNPC1KDM4EALDH1A1 | |
| SCHEMBL6508233 | 0.90 | TLR7 (0.50) | GAAMAPTNPC1KDM4EALDH1A1 | |
| SCHEMBL11335679 | 0.90 | TLR7 (0.50) | GAAMAPTNPC1KDM4EALDH1A1 | |
| SCHEMBL6509500 | 0.83 | KMT2A (0.49) | GAAMAPTNPC1KDM4EALDH1A1 | |
| SCHEMBL6511066 | 0.83 | KMT2A (0.52) | GAAMAPTNPC1KDM4EALDH1A1 | |
| SCHEMBL11339687 | 0.82 | GAA (0.53) | GAAMAPTNPC1KDM4EALDH1A1 | |
| SCHEMBL6510220 | 0.82 | RAB9A (0.50) | GAAMAPTNPC1KDM4EALDH1A1 | |
| SCHEMBL6507276 | 0.81 | KMT2A (0.49) | GAAMAPTNPC1KDM4EALDH1A1 | |
| SCHEMBL6507685 | 0.80 | KMT2A (0.55) | GAAMAPTNPC1KDM4EALDH1A1 | |
| SCHEMBL6508648 | 0.80 | KMT2A (0.52) | GAAMAPTNPC1KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-100374427-C | Cyclic compound, process for producing the same, and pest control agent | SUMITOMO CHEM TAKEDA AGRO CO (JP) | 2008-03-12 | — | — | CN | disclosed |
| CN-101108830-A | Cyclic compound, process for producing the same, and pest control agent | SUMITOMO CHEM TAKEDA AGRO CO (JP) | 2008-01-23 | — | — | CN | disclosed |
| CN-101003517-A | Cyclic compound, process for producing the same, and pest control agent | SUMITOMO CHEM TAKEDA AGRO CO (JP) | 2007-07-25 | — | — | CN | disclosed |
| CN-1649850-A | Cyclic compound, process for producing the same, and pest control agent | SUMITOMO CHEM TAKEDA AGRO CO (JP) | 2005-08-03 | — | — | CN | disclosed |
| US-20050159599-A1 | Cyclic compound, process for producing the same, and pest control agent | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-07-21 | — | — | US | disclosed |
| EP-1481972-A1 | CYCLIC COMPOUND, PROCESS FOR PRODUCING THE SAME, AND PEST CONTROL AGENT | Sumitomo Chemical Takeda Agro Company, Limited (JP) | 2004-12-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050159599-A1 | Cyclic compound, process for producing the same, and pest control agent | CNPY2, CNPY3, HAX1 | GAA 4610/4885MAPT 4484/4885NPC1 2157/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.